首页> Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology> Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.

Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.

导出原文传递

翻译打印收藏纠错

第一作者： Eun-Jeong,Kim

第一单位： Division of Cardiovascular Medicine, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA 94143, USA.

作者： Eun-Jeong,Kim ^[1] ; Benjamin B,Holmes ^[2] ; Shi,Huang ^[3] ; Ricardo,Lugo ^[2] ; Asad,Al Aboud ^[2] ; Stacey,Goodman ^[4] ; Rebecca R,Hung ^[2] ; David,Slosky ^[2] ; William G,Stevenson ^[2] ; Gregory F,Michaud ^[2] ; Roy M,John ^[5]

作者单位： Division of Cardiovascular Medicine, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA 94143, USA. ^[1] Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. ^[2] Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA. ^[3] Division of Hematology and Oncology, Department of MedicineVanderbilt University Medical Center, Nashville, TN 37232, USA. ^[4] Cardiac Arrhythmia Service, Northshore University Medical Center, Cohen 1, 300 Community Drive, Manhasset, NY 11030, USA. ^[5]

关键词 Amyloid Cardiac arrhythmia Cardiomyopathy Implanted cardioverter-defibrillator Sudden cardiac death